ST. PAUL, Minn.--(BUSINESS WIRE)--Torax Medical announced today the forthcoming completion of a second 5-year clinical trial for the LINX procedure to treat gastro-esophageal reflux disease (GERD).
One in five Americans suffers from gastroesophageal reflux disease (GERD), known colloquially as acid reflux. Acid reflux is a digestive disorder in in which acid backs up from the stomach into the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results